PV pharm branch, vendor, cage 0U9U0
Ended Awarded Last action
- Contract number
- SPE2D826F12LH
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $311,882
Award facts
- Contract value 100% obligated
- $311,882.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, valued at $311,882.32 with an ultimate completion date of January 7, 2026, was awarded on January 6, 2026, to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., by the Defense Logistics Agency Medical Supply Chain. The contract is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The work will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a task order under the larger Indefinite Delivery Contract (IDC) held by the parent company Cencora with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for supplying pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, through its parent company Cencora, is a major pharmaceutical distributor providing a comprehensive range of medical products to federal government agencies, including specialty medications, brand-name and generic drugs, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The company supplies critical medical products to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. This delivery order falls under the broader pharmaceutical supply strategy supporting military treatment facilities and veterans' healthcare programs, with the DLA Troop Support Medical planning to establish next-generation Pharmaceutical Prime Vendor Global Program contracts with multiple regional awards to maintain robust pharmaceutical supply capabilities.
Quick answers
Who was awarded contract SPE2D826F12LH?
SPE2D826F12LH was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on January 6, 2026.
How much is contract SPE2D826F12LH worth?
The government has obligated $311,882 on SPE2D826F12LH.
Is contract SPE2D826F12LH an order under another contract?
Yes. SPE2D826F12LH is a delivery order under SPE2DX22D0020, an indefinite delivery contract.
Was contract SPE2D826F12LH competed?
The extent of competition for SPE2D826F12LH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award